Treating myasthenia gravis with autologous hematopoietic stem cell transplants
Monday, April 4, 2016 - 14:00
in Health & Medicine
A report on seven cases of severe myasthenia gravis (an autoimmune disease characterized by severe muscle weakness) suggests that autologous hematopoietic stem cell transplantation (when a patient's own stem cells are used) may result in long-term remission that is symptom and treatment free, according to an article.